Relapsed multiple myeloma demands specialist expertise that goes beyond general oncology. Academic centers with dedicated myeloma programs offer access to clinical trials, advanced cytogenetic interpretation, and treatment-line sequencing strategies that can significantly impact outcomes. Key Takeaways Seek second opinions from dedicated myeloma programs at academic medical centers with specialists who actively participate in clinical trials and interpret cytogenetic markers

TL;DR When compared to single-specialty treatment approaches, multidisciplinary breast cancer care increases 5-year survival rates by up to 25%. Dr. India's multidisciplinary breast cancer treatment is led by Dr. Bharat Patodiya , where integrated teams of medical oncologists, surgical specialists, and radiation specialists collaborate. Advanced diagnostic technologies, specialized breast cancer units, tumor board capabilities, and coordinated care pathways are important